Breaking News Instant updates and real-time market news.

CNDT

Conduent

$19.87

-0.16 (-0.80%)

, CTSH

Cognizant

$75.43

-0.13 (-0.17%)

07:00
08/14/18
08/14
07:00
08/14/18
07:00

JPMorgan upgrades Conduent, downgrades Cognizant and Genpact

JPMorgan analyst Tien-tsin Huang rebalanced his ratings in the IT/BPO Services sector while establishing 2019 price targets. Analyst Puneet Jain upgraded Conduent (CNDT) to Overweight from Neutral with a $24 price target. Jain is more confident that the company's turnaround can unlock earnings power based on first half of 2018 results. He recommends the stock along with DXC Technology (DXC) "among legacy IT services firms in transition." Huang downgraded Cognizant Technology Solutions to Neutral from Overweight saying there is "less margin for error at this point of its turnaround to expand margins and drive revenue growth." The analyst also downgrades Genpact (G) to Underweight from Neutral saying the company ranks at the bottom in terms of price target upside with only 9% upside. Further, the company faces the "burden of higher revenue growth expectations when a wait-and-see approach seems more prudent to us before assigning a higher target multiple," Huang tells investors in a research note.

CNDT

Conduent

$19.87

-0.16 (-0.80%)

CTSH

Cognizant

$75.43

-0.13 (-0.17%)

G

Genpact

$30.23

-0.13 (-0.43%)

DXC

DXC Technology

$84.54

-1.6 (-1.86%)

  • 14

    Aug

  • 15

    Aug

  • 15

    Aug

  • 16

    Aug

  • 12

    Sep

CNDT Conduent
$19.87

-0.16 (-0.80%)

03/06/18
NEED
03/06/18
UPGRADE
Target $25
NEED
Buy
Conduent upgraded to Buy from Hold at Needham
As reported earlier, Needham analyst Mayank Tandon upgraded Conduent to Buy from Hold with a $25 price target. The analyst states that his deeper valuation analysis suggests that the stock is trading "at trough levels compared to historical ranges for the peer group". Tandon adds that he expects to see announcements on Conduent's divestment of lower-margin non-core assets while delevering the company's balance sheet.
08/14/18
JPMS
08/14/18
UPGRADE
Target $24
JPMS
Overweight
Conduent upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Tien-tsin Huang upgraded Conduent to Overweight with an unchanged price target of $24.
06/27/18
JPMS
06/27/18
NO CHANGE
JPMS
Molina's Medicaid solutions sale to DXC negative for Conduent, says JPMorgan
JPMorgan analyst Tien-tsin Huang notes that Molina (MOH) announced its intent to sell its Medicaid Management System to DXC Technology (DXC) for a total purchase price of $220M. The analyst is encouraged with the deal as it strengthens DXC's positioning in the Medicare and Medicaid implementation segment, as he anticipates the combined company to serve 24 U.S. states/regions. However, Huang views the deal to be competitively negative for Conduent (CNDT), who implements MMIS for 10 states/regions in the U.S. The analyst reiterates an Overweight rating on DXC's shares and a Neutral rating on Conduent.
03/06/18
SUSQ
03/06/18
INITIATION
Target $23
SUSQ
Positive
Conduent initiated with a Positive at Susquehanna
Susquehanna analyst James Friedman initiated Conduent with a Positive and $23 price target.
CTSH Cognizant
$75.43

-0.13 (-0.17%)

08/02/18
BREN
08/02/18
NO CHANGE
Target $90
BREN
Buy
Cognizant earnings selloff an overreaction, says Berenberg
Berenberg analyst Georgios Kertsos views the post-earnings selloff in shares of Cognizant as an overreaction. The analyst believes the "sharp margin recovery" in the quarter is the key takeaway. He continues to expect management to meet its fiscal 2019 EBIT margin guidance of 22%, and believes this is not currently priced into the stock. Kertsos keeps a Buy rating on Cognizant with a $90 price target.
08/14/18
JPMS
08/14/18
DOWNGRADE
Target $87
JPMS
Neutral
Cognizant downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Tien-tsin Huang downgraded Cognizant Technology Solutionsto Neutral while raising his price target for the shares to $87 from $86.
08/02/18
BARD
08/02/18
NO CHANGE
Target $90
BARD
Outperform
Cognizant move down after earnings 'a little much,' says Baird
Baird analyst David Koning noted that Cognizant's after Q2 revenue and Q3 guidance were below consensus, but he also notes that its 2018 revenue guidance was reiterated and its EPS guidance slightly raised. He feels the 7% move lower is "a little much" and believes the valuation seems attractive at current levels. Koning, who thinks 10%-15% EPS growth seems likely for Cognizant over the next few years, keeps an Outperform rating and $90 price target on the stock.
07/17/18
WOLF
07/17/18
INITIATION
Target $95
WOLF
Peer Perform
Cognizant initiated with a Peer Perform at Wolfe Research
Wolfe Research analyst Darrin Peller started Cognizant with a Peer Perform rating and $95 price target.
G Genpact
$30.23

-0.13 (-0.43%)

11/15/17
BARD
11/15/17
NO CHANGE
Target $38
BARD
Outperform
Genpact may be weak after Bain share sale, but downside risk limited, says Baird
Baird analyst David Koning noted the secondary offering of Genpact was Bain Capital selling shares, but said they will still retain a 25% stake in the company. The analyst believes the shares will be weak following the offering, but views the risk/reward as very good with downside risk limited. Koning reiterated his Outperform rating and $38 price target on Genpact shares.
08/08/18
COWN
08/08/18
NO CHANGE
Target $37
COWN
Outperform
Genpact weakness a buying opportunity, says Cowen
Cowen analyst Bryan Bergin said he would be a buyer of Genpact if the shares are weak following its earnings report. He notes the revenues were light but it was offset by notably bullish pipeline, bookings, and large deal commentary, margin improvement, and solid guidance. Bergin said the positives outweigh the negatives and he reiterated his Outperform rating and $37 price target on Genpact shares.
08/14/18
JPMS
08/14/18
DOWNGRADE
Target $33
JPMS
Underweight
Genpact downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Tien-tsin Huang downgraded Genpact to Underweight and lowered his price target for the shares to $33 from $34.
02/13/18
BMOC
02/13/18
NO CHANGE
Target $35
BMOC
Market Perform
Genpact price target raised to $35 from $32 at BMO Capital
BMO Capital analyst Keith Bachman raised his price target on Genpact (G) to $35, saying the company's revenue growth trajectory is improving thanks to the "strong demand environment, solid execution, and lower revenue mix impact from General Electric (GE)". The analyst contends that revenue growth rates can accelerate further if Global Clients can grow 10% per year and GE stabilizes. Bachman keeps his Market Perform rating on Genpact, noting that the stock price gains are limited because operating and free cash flow margins will not improve "meaningfully".
DXC DXC Technology
$84.54

-1.6 (-1.86%)

07/13/18
SUSQ
07/13/18
NO CHANGE
Target $125
SUSQ
Positive
DXC Technology worth 'at least $102' in possible split, says Susquehanna
Susquehanna analyst James Friedman kept his Positive rating and $125 price target on DXC Technology, speculating that if the company tried to split the Growth business from its Core, he would value the assets at "at least $102" per share and possibly "much more". The analyst notes that a spin-off for Growth could add at least 20% to its value, and his discussions with CEO Lawrie in the past have suggested that he could split the company, with "one run for growth and the other run for margin."
07/17/18
WOLF
07/17/18
INITIATION
Target $120
WOLF
Outperform
DXC Technology initiated with an Outperform at Wolfe Research
Wolfe Research analyst Darrin Peller initiated DXC Technology with an Outperform and $120 price target.
08/08/18
SBSH
08/08/18
NO CHANGE
Target $106
SBSH
Buy
DXC Technology remains a top idea at Citi
Citi analyst Ashwin Shirvaikar says DXC Technology remains a top idea following the company's Q1 results. DXC delivered "solid" margins and earnings to start the year, Shirvaikar tells investors in a post-earnings research note. The analyst finds it equally importantly that management "spoke strongly" about a trajectory of improving margins and raised their earnings outlook to the top of the prior range. Shirvaikar keeps a Buy rating on DXC Technology with a $106 price target.
08/06/18
MSCO
08/06/18
NO CHANGE
MSCO
Boeing, Tesla, Nvidia make Morgan Stanley 'key man risk' list
Morgan Stanley equity strategist Mark Savino noted that about 12% of CEO jobs among S&P 500 companies turned over in 2017, noting that this was the highest level of CEO departures since before the financial crisis. The 59 stocks of S&P 500 companies that had CEOs depart in 2017 underperformed the market by 11% over the next 12 months, or since the departure for instances that were less than 12 months ago, noted Savino. In cooperation with the firm's U.S. analysts, Savino and his team identified the companies in each sector they believe face the greatest level of "key man risk," which includes: Boeing (BA), Tesla (TSLA), ADT Inc. (ADT), Moody's (MCO), TransUnion (TRU), Arista Networks (ANET), Church & Dwight (CHD), Coca-Cola (KO), Monster Beverage (MNST), Coupa Software (COUP), Salesforce (CRM), FireEye (FEYE), MongoDB (MDB), Microsoft (MSFT), New Relic (NEWR), XPO Logistics (XPO), Hilton (HLT), Las Vegas Sands (LVS), Best Buy (BBY), Ulta (ULTA), Aflac (AFL), Athene Holding (ATH), Lincoln National (LNC), Arthur J. Gallagher (AJG), Chubb (CB), Amazon.com (AMZN), Activision Blizzard (ATVI), Facebook (FB), Alphabet (GOOGL), Apple (AAPL), Terex (TEX), Cleveland-Cliffs (CLF), Freeport McMoRan (FCX), FleetCor (FLT), Global Payments (GPN), Square (SQ), Jazz Pharmaceuticals (JAZZ), Cheesecake Factory (CAKE), Broadcom (AVGO), Nvidia (NVDA), Chegg (CHGG), DXC Technology (DXC), Medidata (MDSO), Pluralsight (PS), RealPage (RP), Shopify (SHOP) and T-Mobile (TMUS).

TODAY'S FREE FLY STORIES

03:05
12/10/18
12/10
03:05
12/10/18
03:05
General news
FX Update: The Dollar and Sterling have come under general pressure »

FX Update: The Dollar…

YELP

Yelp

$34.60

0.19 (0.55%)

20:47
12/09/18
12/09
20:47
12/09/18
20:47
Periodicals
Yelp holder SQN to send letter pushing for business review, WSJ reports »

SQN Investors, a 4%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

GILD

Gilead

$68.17

-2.01 (-2.86%)

, RHHBY

Roche

$0.00

(0.00%)

20:38
12/09/18
12/09
20:38
12/09/18
20:38
Periodicals
Gilead to hire Roche's Daniel O'Day as next CEO, WSJ reports »

Gilead Sciences (GILD)…

GILD

Gilead

$68.17

-2.01 (-2.86%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 24

    Dec

  • 18

    Mar

UN

Unilever; also tag UL

$55.49

0.13 (0.23%)

, UL

Unilever; also tag UN

$54.04

0.17 (0.32%)

20:29
12/09/18
12/09
20:29
12/09/18
20:29
Downgrade
Unilever; also tag UL, Unilever; also tag UN rating change at JPMorgan »

Unilever downgraded to…

UN

Unilever; also tag UL

$55.49

0.13 (0.23%)

UL

Unilever; also tag UN

$54.04

0.17 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

JELD

Jeld-Wen

$16.85

-0.61 (-3.49%)

20:27
12/09/18
12/09
20:27
12/09/18
20:27
Downgrade
Jeld-Wen rating change at Goldman Sachs »

Jeld-Wen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBHS

Fortune Brands

$42.60

0.07 (0.16%)

20:27
12/09/18
12/09
20:27
12/09/18
20:27
Upgrade
Fortune Brands rating change at Goldman Sachs »

Fortune Brands upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANPDY

Anta Sports Products

$0.00

(0.00%)

19:46
12/09/18
12/09
19:46
12/09/18
19:46
Downgrade
Anta Sports Products rating change at Deutsche Bank »

Anta Sports Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KREF

KKR Real Estate Finance

$19.71

-0.095 (-0.48%)

19:42
12/09/18
12/09
19:42
12/09/18
19:42
Upgrade
KKR Real Estate Finance rating change at Keefe Bruyette »

KKR Real Estate upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KTOS

Kratos Defense

$13.64

-0.11 (-0.80%)

19:34
12/09/18
12/09
19:34
12/09/18
19:34
Upgrade
Kratos Defense rating change at Goldman Sachs »

Kratos Defense upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$168.37

-6.37 (-3.65%)

, MSFT

Microsoft

$104.90

-4.27 (-3.91%)

19:30
12/09/18
12/09
19:30
12/09/18
19:30
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

AAPL

Apple

$168.37

-6.37 (-3.65%)

MSFT

Microsoft

$104.90

-4.27 (-3.91%)

DIS

Disney

$112.00

-1.385 (-1.22%)

PYPL

PayPal

$82.78

-3.07 (-3.58%)

AMAT

Applied Materials

$33.65

-1.04 (-3.00%)

CAT

Caterpillar

$123.54

-4.69 (-3.66%)

LEN

Lennar

$42.00

-0.43 (-1.01%)

NFLX

Netflix

$265.14

-17.66 (-6.24%)

PANW

Palo Alto Networks

$175.11

-6.73 (-3.70%)

DB

Deutsche Bank

$8.74

-0.155 (-1.74%)

LITE

Lumentum

$41.92

-2.81 (-6.28%)

OCLR

Oclaro

$8.27

-0.165 (-1.96%)

FNSR

Finisar

$22.49

-0.53 (-2.30%)

ZTCOY

ZTE Corp.

$0.00

(0.00%)

CIEN

Ciena

$31.30

-0.95 (-2.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 13

    Dec

  • 13

    Dec

  • 18

    Dec

  • 19

    Dec

  • 09

    Jan

  • 10

    Jan

  • 03

    Mar

LITE

Lumentum

$41.92

-2.81 (-6.28%)

, OCLR

Oclaro

$8.27

-0.165 (-1.96%)

18:16
12/09/18
12/09
18:16
12/09/18
18:16
Periodicals
Huawei CFO seeking bail, Reuters reports »

Huawei Chief Financial…

LITE

Lumentum

$41.92

-2.81 (-6.28%)

OCLR

Oclaro

$8.27

-0.165 (-1.96%)

FNSR

Finisar

$22.49

-0.53 (-2.30%)

ZTCOY

ZTE Corp.

$0.00

(0.00%)

INFN

Infinera

$4.38

-0.21 (-4.58%)

CIEN

Ciena

$31.30

-0.95 (-2.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

KERX

Keryx

$3.14

-0.035 (-1.10%)

, AKBA

Akebia

$8.52

-0.02 (-0.23%)

16:51
12/09/18
12/09
16:51
12/09/18
16:51
Conference/Events
Akebia to host special shareholder meeting »

Special Shareholder…

KERX

Keryx

$3.14

-0.035 (-1.10%)

AKBA

Akebia

$8.52

-0.02 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

AKBA

Akebia

$8.52

-0.02 (-0.23%)

, KERX

Keryx

$3.14

-0.035 (-1.10%)

16:49
12/09/18
12/09
16:49
12/09/18
16:49
Conference/Events
Keryx to host special shareholder meeting »

Special Shareholder…

AKBA

Akebia

$8.52

-0.02 (-0.23%)

KERX

Keryx

$3.14

-0.035 (-1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

DVMT

Dell Technologies

$104.01

-1.51 (-1.43%)

16:35
12/09/18
12/09
16:35
12/09/18
16:35
Conference/Events
Dell Technologies to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 07

    Mar

T

AT&T

$30.14

-0.38 (-1.25%)

, CMCSA

Comcast

$37.41

-0.46 (-1.21%)

16:34
12/09/18
12/09
16:34
12/09/18
16:34
Hot Stocks
Box Office Battle: 'Ralph Breaks the Internet' leads top office with $16.1M »

Disney's (DIS)…

T

AT&T

$30.14

-0.38 (-1.25%)

CMCSA

Comcast

$37.41

-0.46 (-1.21%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$51.19

-0.67 (-1.29%)

FOX

21st Century Fox

$48.99

-0.23 (-0.47%)

FOXA

21st Century Fox

$49.26

-0.21 (-0.42%)

LGF.A

Lionsgate

$17.58

0.28 (1.62%)

DIS

Disney

$112.00

-1.385 (-1.22%)

VIAB

Viacom

$29.91

-0.09 (-0.30%)

VIA

Viacom

$33.19

0.11 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 30

    Jan

  • 20

    Mar

CNC

Centene

$133.28

-2.1 (-1.55%)

16:09
12/09/18
12/09
16:09
12/09/18
16:09
Conference/Events
Centene to hold a meeting »

2019 Financial Guidance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

FTI

TechnipFMC

$21.00

-0.69 (-3.18%)

16:00
12/09/18
12/09
16:00
12/09/18
16:00
Conference/Events
TechnipFMC to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRX

Catalyst Pharmaceuticals

$2.39

0.16 (7.17%)

15:56
12/09/18
12/09
15:56
12/09/18
15:56
Conference/Events
Catalyst Pharmaceuticals to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

WPP

WPP

$52.11

-0.39 (-0.74%)

14:22
12/09/18
12/09
14:22
12/09/18
14:22
Conference/Events
WPP to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

VISI

Volt Information Sciences

$2.64

-0.05 (-1.86%)

14:11
12/09/18
12/09
14:11
12/09/18
14:11
Conference/Events
Volt Information Sciences to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ARCT

Arcturus Therapeutics

$5.90

0.45 (8.26%)

13:52
12/09/18
12/09
13:52
12/09/18
13:52
Conference/Events
Arcturus Therapeutics to hold a conference call »

Key Opinion Leader…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

STWD

Starwood Property

$22.34

-0.08 (-0.36%)

13:37
12/09/18
12/09
13:37
12/09/18
13:37
Conference/Events
Starwood Property to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

EZPW

Ezcorp

$8.74

-0.17 (-1.91%)

13:31
12/09/18
12/09
13:31
12/09/18
13:31
Conference/Events
Ezcorp to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

NFLX

Netflix

$265.14

-17.66 (-6.24%)

, PANW

Palo Alto Networks

$175.11

-6.73 (-3.70%)

13:20
12/09/18
12/09
13:20
12/09/18
13:20
Periodicals
Netflix, Palo Alto offer growth at a discount, Barron's says »

As stocks search for a…

NFLX

Netflix

$265.14

-17.66 (-6.24%)

PANW

Palo Alto Networks

$175.11

-6.73 (-3.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 19

    Dec

  • 09

    Jan

  • 10

    Jan

DHR

Danaher

$101.94

-2.88 (-2.75%)

13:18
12/09/18
12/09
13:18
12/09/18
13:18
Conference/Events
Danaher to host analyst and investor meeting »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.